e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

📢 Latest Update: Call for Papers – Special Issue on Pharmacy and Health Research (April 2026 Submission Deadline)

📢 Latest Update: Call for Papers – Special Issue on Pharmacy and Health Research (April 2026 Submission Deadline)

Volume 1, Issue 2 - 2013 (May 2013 Issue 2)

Volume 1 Issue 2 Cover

Issue Details:

Volume 1 Issue 2
Published:Invalid Date

Editorial: May 2013 Issue 2

Welcome to the 2013 issue of American Journal of Pharmacy and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr. Hemangi J Patel
Editor-in-Chief
American Journal of Pharmacy and Health Research

Articles in This Issue

Showing 5 of 5 articles
Research PaperID: AJPHR12001

Matrix tablet: A Promising Technique for Controlled Drug Delivery

Ravikumar Misal, Atish Waghmare, Vijay Toshniwal

From the last decade great interest generated on replacing conventional administration of drug by delivery system which would release effective quantities from a protected supply at a controlled rate over a long period of time. An appropriately designated controlled release drug delivery system is the major advance toward solving problems concerning targeting of a drug to a specific organ or a tissue and controlling the rate of a drug delivery to the target site. Matrix system are favoured because of their simplicity, patient compliance etc, than traditional drug delivery(TDS) which have many drawbacks like repeated administration, fluctuation in blood concentration level etc. Developing oral sustained release matrix tablet with constant release rate has always been a challenge to the pharmaceutical technologist. Most of drugs, if not formulated properly, may readily release the drug at a faster rate, and are likely to produce toxic concentration of the drug on oral administration. So that selecting appropriate polymers have become product of choice as an important ingredient for formulating sustained release formulations.

Sustained releaseConventional tabletControlled release systemMatrix tablet.
2,011 views
568 downloads

Contributors:

 Ravikumar Misal
,
 Atish Waghmare
,
 Vijay Toshniwal
Research PaperID: AJPHR12002

A QSAR Study on cFMS Inhibitors As Potential Anti-Inflammatory Agents: The 2´-Aminoanilide Derivatives

Brij Kishore Sharma, Pradeep Pilania, Prithvi Singh, Yashwant

The cFMS inhibitory activity of 2´-aminoanilide derivatives has been quantitatively analyzed in terms of Dragon descriptors using CP-MLR. The analysis has provided a rational approach for the development of new 2´-aminoanilide   derivatives, the cFMS inhibitors, as potential anti-inflammatory agents. The descriptors identified in CP-MLR analysis have highlighted the role of atomic properties in respective lags of 2D-autocorrelations (MATS7m, MATS5v and GATS2p), path/walk ratio 2-Randic shape index (PW2) and Lovasz-Pelikans’ leading eigenvalue index (LP1) to explain the biological actions of 2´-aminoanilide derivatives as cFMS inhibitors. Certain structural fragment (C-001) and functionality (nCrHR) in molecular structures have also shown prevalence to optimize the cFMS inhibitory activity of titled compounds. Applicability domain analysis revealed that the suggested model matches the high quality parameters with good fitting power and the capability of assessing external data and all of the compounds was within the applicability domain of the proposed model and were evaluated correctly.

QSAR2´-AminoanilidescFMS inhibitorsanti-inflammatory agentscombinatorial protocol in multiple linear regression (CP-MLR).
1,846 views
717 downloads

Contributors:

 Brij Kishore Sharma
,
 Pradeep Pilania
,
 Prithvi Singh
,
 Yashwant
Research PaperID: AJPHR12003

Development and Optimization of Fast Dissolving Film of Losartan Potassium

Hemangi J. Patel, Parth B. Patel, Kamal M. Kamdar, Kinjal B. Patel, Arpan A. Shah, Zil P. Patel

The present work aims to prepare fast dissolving films of Losartan Potassium with purpose of developing rapid onset of action, which is very convenient for administration without using water. Fast dissolving films are meant to be dissolved in saliva and remain in oral cavity until swallowed. The films were prepared by solvent casting method and characterized by UV, DSC studies. The plasticizer concentration was selected on the basis of flexibility, tensile strength and stickiness of the film. In the present study polyethylene glycol was used as plasticizes. Fast dissolving films were evaluated for drug content and the drug loading capacity. The dissolution profile and folding endurance were found to be satisfactory. The disintegration time of formulation F3 film was lowest (30 sec), so they release drug faster than other formulations. A drug-excipients interaction was performed by DSC and FTIR; results were shown that there was no interaction between drug and excipients used. In vitro release mechanism was evaluated by subjecting  the dissolution data to various kinetic models and the drug release was found to best fit the Korsemeyer-peppas model. Hence it is concluded that Losartan Potassium fast dissolving films are successfully developed and evaluated. Key Words: Fast dissolving films, Losartan Potassium, Solvent casting method, Hypertension  

Fast dissolving filmsLosartan PotassiumSolvent casting methodHypertension
2,014 views
754 downloads

Contributors:

 Hemangi J. Patel
,
 Parth B. Patel
,
 Kamal M. Kamdar
,
 Kinjal B. Patel
,
 Arpan A. Shah
,
 Zil P. Patel
Research PaperID: AJPHR12004

Formulation and Evaluation of Floating Microspheres of Etodolac

Hemant Yadav, Hemangi Patel

Etodolac is a non steroidal anti-inflammatory drug. it is an inhibitor of cycloxygenase which belongs to the pyranocarboxylic acid group. Which is effective in treating fever, pain, and inflammation in the body. which is degraded in stomach .Thus, the purpose of the study is to formulate a dosage form which is coated by coating polymer(s) which passed the acidic medium and exhibit significant effect in intestine. An attempt was made to formulate microspheres with two coating polymers: HPMC & Ethyl Cellulose as well as using of floating properties of polymers will release drug in controlled manner. Thus, these different type of microspheres was characterized in terms of Particles size, buoyancy study, Entrapment efficiency and In-vitro studies.

EtodolacCoating polymers. etc.
1,987 views
680 downloads

Contributors:

 Hemant Yadav
,
 Hemangi Patel
Research PaperID: AJPHR12005

Development and Validation for Simultaneous Estimation of Ciprofloxacin HCl, Doxycycline and Phenazopyridine HCl in Combined Dosage Form by U.V Method

Gajanan Jalindar Chavan, Swapnali Roshan Charya, Ioan Nuw Baris, Sachin Dhondiram Patil

A simple, sensitive, accurate and precise simultaneous UV spectrophotometric method has been developed for the estimation of Ciprofloxacin HCL, Doxycycline Hyclate  and Phenazopyridine HCL in tablet dosage form .The absorption maxima of the drugs were found to be 277, 273 and 392 nm for Ciprofloxacin HCL, Doxycycline Hyclate  and Phenazopyridine HCL respectively, in water, using a Shimadzu UV–Visible spectrophotometer (model UV-1800). Ciprofloxacin HCL, Doxycycline Hyclate  and Phenazopyridine HCL in obeyed Beer’s law in the concentration range of 2-10 μg ml-1, 2-10 μg ml-1 and 2-10 μg ml-1 respectively. The correlation coefficient was found to be 0.999, 0.999, and 0.999 for Ciprofloxacin HCL, Doxycycline Hyclate  and Phenazopyridine HCL respectively .The method was validated for various parameters according to ICH guidelines. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed method. Assay results were in good agreement with label claim.

Ciprofloxacin HCL (CIPRO)Doxycycline Hyclate(DOXY) and Phenazopyridine HCL(PHENA)UV spectrophotometric methodsimultaneous equation method.
2,471 views
810 downloads

Contributors:

 Gajanan Jalindar Chavan
,
 Swapnali Roshan Charya
,
 Ioan Nuw Baris
,
 Sachin Dhondiram Patil